Compositions and methods relating to resveratrol
AssigneeWilmore Labs L.L.C
InventorOtis L. Blanchard
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods comprising resveratrol and uses thereof. Some embodiments include compositions and methods with increased bioavailability of resveratrol. Certain embodiments include compositions comprising resveratrol and a solubilizer. Particular embodiments include transmucosal delivery of resveratrol from the composition.
Claims21
A pharmaceutical composition comprising resveratrol and a solubilizer in a buccal, sublingual or gingival dosage form, wherein said solubilizer is selected from the group consisting of ribose, arabinose, glucose, deoxyribose and mixtures thereof, wherein an amount of said resveratrol to solubilizer in the dosage form of said pharmaceutical composition in in the range of about 5 mg/g to about 1,000 mg/g.
A pharmaceutical composition comprising resveratrol and a solubilizer in a buccal, sublingual or gingival dosage form suitable for enhancing serum bioavailability of resveratrol in a subject, wherein said solubilizer is selected from the group consisting of ribose, arabinose, glucose, deoxyribose and mixtures thereof, and wherein an amount of said resveratrol to solubilizer in the dosage form of said pharmaceutical composition is in the range of about 20 mg/g to about 100 mg/g.
A pharmaceutical composition comprising resveratrol and a solubilizer in a buccal, sublingual or gingival dosage form suitable for enhancing serum bioavailability of resveratrol in a subject, wherein said solubilizer consists essentially of ribose, arabinose, glucose, deoxyribose or mixtures thereof, and wherein an amount of resveratrol to solubilizer in the dosage form is in the range of about 20 mg/g to about 100 mg/g.
Dependencies are inferred from the claim text.